Value Aligned Research Advisors LLC Raises Position in BKV Corporation $BKV

Value Aligned Research Advisors LLC increased its stake in BKV Corporation (NYSE:BKV) by 110.5% in the second quarter, according to the company in its most recent disclosure with the SEC. The institutional investor owned 679,899 shares of the company’s stock after buying an additional 356,848 shares during the quarter. Value Aligned Research Advisors LLC’s holdings in BKV were worth $18,602,000 as of its most recent filing with the SEC.

Other hedge funds and other institutional investors have also recently bought and sold shares of the company. BlackRock Inc. purchased a new stake in shares of BKV during the second quarter valued at approximately $74,241,000. William Blair Investment Management LLC purchased a new stake in BKV during the 2nd quarter worth $32,689,000. Bank of America Corp DE purchased a new stake in BKV during the 2nd quarter worth $16,177,000. Bank of New York Mellon Corp acquired a new position in BKV in the 2nd quarter worth $15,261,000. Finally, Cooper Creek Partners Management LLC boosted its position in BKV by 24.7% in the 1st quarter. Cooper Creek Partners Management LLC now owns 2,103,230 shares of the company’s stock valued at $59,984,000 after buying an additional 416,281 shares during the last quarter.

Insiders Place Their Bets

In other BKV news, insider Lindsay Larrick sold 10,000 shares of BKV stock in a transaction that occurred on Friday, August 14th. The stock was sold at an average price of $26.16, for a total value of $261,600.00. Following the completion of the transaction, the insider directly owned 83,925 shares in the company, valued at $2,195,478. The trade was a 10.65% decrease in their ownership of the stock. The sale was disclosed in a legal filing with the SEC, which is available at this link. The transaction was executed under a pre-arranged Rule 10b5-1 trading plan. Also, CFO David Tameron sold 4,321 shares of the company’s stock in a transaction that occurred on Thursday, August 20th. The shares were sold at an average price of $26.56, for a total value of $114,765.76. Following the transaction, the chief financial officer directly owned 58,524 shares of the company’s stock, valued at $1,554,397.44. This trade represents a 6.88% decrease in their ownership of the stock. The SEC filing for this sale provides additional information. The transaction was executed under a pre-arranged Rule 10b5-1 trading plan. Insiders have sold 28,198 shares of company stock valued at $733,271 over the last quarter. Insiders own 2.51% of the company’s stock.

BKV Stock Performance

BKV stock opened at $26.04 on Friday. The stock’s 50 day simple moving average is $25.47 and its 200 day simple moving average is $27.26. BKV Corporation has a 12-month low of $20.08 and a 12-month high of $32.81. The firm has a market cap of $2.85 billion, a P/E ratio of 9.50 and a beta of 1.06. The company has a current ratio of 1.15, a quick ratio of 1.10 and a debt-to-equity ratio of 0.45.

BKV (NYSE:BKV) last released its earnings results on Thursday, August 6th. The company reported $0.46 earnings per share for the quarter, beating the consensus estimate of $0.25 by $0.21. BKV had a net margin of 17.73% and a return on equity of 6.67%. The firm had revenue of $465.54 million during the quarter, compared to analyst estimates of $355.25 million. As a group, equities research analysts predict that BKV Corporation will post 1.77 EPS for the current year.

Analyst Ratings Changes

Several research analysts recently commented on BKV shares. Citigroup cut their price target on BKV from $36.00 to $33.00 and set a “buy” rating on the stock in a research note on Thursday, June 11th. Wall Street Zen lowered BKV from a “sell” rating to a “strong sell” rating in a research report on Saturday. Susquehanna decreased their price target on shares of BKV from $37.00 to $35.00 and set a “positive” rating for the company in a research report on Tuesday, July 21st. Jefferies Financial Group restated a “buy” rating and issued a $34.00 price target on shares of BKV in a research note on Friday, July 10th. Finally, Zacks Research upgraded shares of BKV from a “strong sell” rating to a “hold” rating in a research note on Monday, June 15th. Eight research analysts have rated the stock with a Buy rating and two have given a Hold rating to the stock. According to data from MarketBeat, BKV currently has a consensus rating of “Moderate Buy” and an average target price of $34.25.

BKV Profile

BKV Corporation engages in the acquisition, operation, and development of natural gas and NGL properties. It is also involved in the gathering, processing, and transportation of natural gas. The company was founded in 2015 and is based in Denver, Colorado with additional offices in Tunkhannock, Pennsylvania and Fort Worth, Texas. BKV Corporation, LLC operates as a subsidiary of Banpu North America Corporation.